1Luo Yusheng,Liao Yuhua,Wang Min,Wei Yumiao,Dong Jihua,Wang Jinping,Lu Yingping. Experimental study on AT1-receptor-peptide-induced myocardial immune damage in rat[J] 2001,Journal of Tongji Medical University(3):198～201
4Widimsky P. Reperfusion damage or no- reflow damage in primary coronary interventions in acute myocardial infarction[J]. Eur Heart J ,2002,23 ( 14 ) : 1076-1078.
5Weaver WD, Simes R J, Betriu A, et ah Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review [ J ]. JAMA, 1997,278 ( 23 ) :2093-2098.
6Lansky AJ, Mehran R, Dangas G, et al. Comparison of differences in outcome after percutaneous coronary intervention in men versus women < 40 years of age [ J ]. Am J Cardiol, 2004,93 (7) :916- 919.
7Peterson ED, Lansky AJ, Kramer J, et al. Effect of gender on the outcomes of contemporary percutaneous coronary intervention [ J ]. Am J Cardiol,2001,88 (4) :359-364.
8Hurst W. The heart, arteries and veins[ M]. 10th ed. New York: McGraw-Hill ,2002 : 84-96.
9KannelWB.Risk stratification in hypertention: new insights from the Framin.心血管病学进展,2005,26:3-10.
10Fiebach NH, Hebert PR, Stampfer MJ, et al. A prospectivestudy of high blood pressure and cardiovascular disease in women[ J]. Am J Epidemia, 1989,130 (4) :646-654.
